These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9312763)

  • 1. [The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers].
    Paczek L; Bill M; Wyzgał J; Gaciong Z; Gradowska L; Juskowa J; Durlik M; Lao M
    Pol Arch Med Wewn; 1997 Feb; 97(2):144-56. PubMed ID: 9312763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
    Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR
    Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M; Eriksson LO; Germershausen JI; Thysell H
    Nephron; 1994; 68(1):57-62. PubMed ID: 7991041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR; Tandon M; Sharma PL
    Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin treatment of hypercholesterolemia in renal transplant recipients.
    Kasiske BL; Tortorice KL; Heim-Duthoy KL; Goryance JM; Rao KV
    Transplantation; 1990 Jan; 49(1):95-100. PubMed ID: 2105548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients.
    Kuo PC; Kirshenbaum JM; Gordon J; Laffel G; Young P; DiSesa VJ; Mudge GH; Vaughan DE
    Am J Cardiol; 1989 Sep; 64(10):631-5. PubMed ID: 2675584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine.
    Cheung AK; DeVault GA; Gregory MC
    J Am Soc Nephrol; 1993 Jun; 3(12):1884-91. PubMed ID: 8338920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL-cholesterol and lipoprotein (a).
    Traindl O; Reading S; Franz M; Watschinger B; Klauser R; Pidlich H; Widhalm K; Pohanka E; Kovarik J
    Nephron; 1992; 62(4):394-8. PubMed ID: 1300434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM; Katyal A
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia].
    Grüneberger S; Dreyer M; Kangah R; Reinicke A; Staisch C; Steinhagen-Thiessen E; Müller P; Simon B; Dammann HG
    Dtsch Med Wochenschr; 1989 Nov; 114(45):1734-9. PubMed ID: 2806106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits.
    Gámez R; Mendoza S; Mas R; Noa M; Arruzazabala L; Carbajal D; Castaño G; Goicochea E; Mesa M; Mendoza N
    Drugs R D; 2003; 4(4):219-29. PubMed ID: 12848586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.